Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread

2012 ◽  
Vol 39 (6) ◽  
pp. 944-955 ◽  
Author(s):  
Chun-Ta Liao ◽  
Kang-Hsing Fan ◽  
Chien-Yu Lin ◽  
Hung-Ming Wang ◽  
Shiang-Fu Huang ◽  
...  
2011 ◽  
Vol 18 (9) ◽  
pp. 2569-2578 ◽  
Author(s):  
Chun-Ta Liao ◽  
Chien-Yu Lin ◽  
Kang-Hsing Fan ◽  
Shiang-Fu Huang ◽  
I-How Chen ◽  
...  

2020 ◽  
pp. 54-58
Author(s):  
Saeed Farzanehfar ◽  
Farahnaz Aghahoseini ◽  
Marzieh Peyman ◽  
Mehrshad Abbasi

Background: The application of FDG PET/CT scan for assessment of patients with breast cancer is increasing. The cost effectiveness of the application could be different in a developing country with limited PET scanners and treatment prioritiesMethods: Open discussions of the PET reviewers from 2 out of 4 PET centers of Tehran, the capital city of Iran, were organized to provide insight into their opinions on the indications of FDG PET in breast cancer patients. Results: The sensitivity of FDG PET scan is high for detection of distant metastases; however, assessment of lymph node pathology and the local extension of the breast cancer are questionable. Considering the cost of the procedure itself and the downstream diagnostic procedures, its application and diagnostic accuracy are hindered for breast cancer screening, staging, and assessment of response to treatment and prognosis. The advantages and disadvantages of FDG PET CT and dedicated breast FDG PET scan have been briefed in different clinical scenarios with a focus on limitations faced by a developing country.Conclusion: We suggest reserving the use of FDG PET for selected cases of suspected but not proven recurrent disease and in patients with high risk of metastasis before high risk surgery.


QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
Y M Mohamed ◽  
S H Sharkawy ◽  
D I Darwish

Abstract Background Under diagnosis of COPD is serious problem in many countries world-wide because there are no generally detection tools available to detect high-risk patients for spirometry, and patients will not go for COPD check-up until a serious issue happens like exacerbation. Objective The aim of the work is trying to assess a new screening tool for early diagnosis of COPD. Patients and Methods The present study was conducted upon 500 subjects during the period from march 2018 to august 2018 who admitted to our chest department or visit our outpatient clinic, employees and visitors to Ain Sham hospitals.All subjects >40yrs who smoker or ex-smoker(≥10pack-years) applied a six variants(age,sex,packed years smoked during life ,dyspnea,chronic phlegmand chronic cohgh)questionnaire modified from PUMA questionnaire Subjects with score ≥5 did spirometry Results 500 subjects shared in the study 497 of them were males ( 99.4% )and 3 were females (.6%). 152of them(30.4%) had score <5 and 348 of them (69.6%)had score ≥5 who did spirometry.152 subjects did not perform spirometry. By spirometry we diagnosed 81(23.3) case COPD (fev1-fvc <.7) out of 348 subjects under gone spirometry and 16.2% of total subjects(500) . Conclusion Modified puma score is a simple and easy screening questionnaire for early detection of COPD cases and spirometry should be done to confirm the diagnosis or rule out.COPD is prevalent in many healthy apparent persons.


2016 ◽  
Vol 28 (2) ◽  
pp. 95-99 ◽  
Author(s):  
Hany Abdel Rahman ◽  
Mohamed Sedky ◽  
Asmaa Hamoda ◽  
Tarek Raafat ◽  
Ayda Youssef ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Abtin Doroudinia ◽  
Behnam Safarpour Lima ◽  
Mehrdad Bakhshayesh Karam ◽  
Niloufar Ghadimi ◽  
Farhad Yousefi

Sign in / Sign up

Export Citation Format

Share Document